Proadrenomedullin (pro-ADM) for the diagnosis of proven and clinical sepsis in a newborn cohort including preterm newborns has not been investigated. We aimed to investigate the value of pro-ADM as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback